Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Hexacosanedioic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003044 AN004993 A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics Blood Human Obesity University of Colorado Denver LC-MS
ST003044 AN004994 A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics Blood Human Obesity University of Colorado Denver LC-MS
ST003036 AN004978 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences LC-MS
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST001796 AN002918 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib Mesenteric lymph Mouse Diabetes Monash Institute of Pharmaceutical Sciences LC-MS
ST000422 AN000670 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000666 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000310 AN000490 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000310 AN000492 TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) Blood Mouse Lupus University of Florida LC-MS
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo